Status:

NOT_YET_RECRUITING

MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads

Lead Sponsor:

Zimmer Biomet

Conditions:

Hip Arthritis

Hip Disease

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the RingLoc Bipolar Aceta...

Detailed Description

The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the RingLoc Bipolar Aceta...

Eligibility Criteria

Inclusion

  • Patient must be 18 years of age or older and skeletally mature
  • Patient must have undergone hip hemiarthroplasty surgery with the RingLoc Bipolar Acetabular Cup or Endo II Femoral Head for a cleared indication, greater than or equal to eight years previous to the date of study consent. Cleared indications for the RingLoc Bipolar and Endo II Heads include the following:
  • Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis
  • Rheumatoid arthritis
  • Correction of functional deformity
  • Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques.

Exclusion

  • Any medical diagnosis present at the time of surgery that, at the Investigator's discretion, could compromise the implant's survivability
  • Off-label use or not according to the approved instructions for use (IFU) of study devices
  • Revision procedures where other treatment or devices have failed
  • Uncooperative patient or patient with neurologic disorders who is incapable of following directions
  • Patient has a psychiatric illness or

Key Trial Info

Start Date :

November 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 3 2030

Estimated Enrollment :

116 Patients enrolled

Trial Details

Trial ID

NCT05199870

Start Date

November 1 2025

End Date

September 3 2030

Last Update

November 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Inova Fairfax Hospital

Falls Church, Virginia, United States, 22042